维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：期刊名="BreastCancer"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Role of dynamiccontrast enhanced MRI in monitoring early response of locallyadvanced breast cancer to neoadjuvant chemotherapy 显示文摘	Pickles MD Lowry M Manton DJ	2005	BreastCancer Res Treat2005，91，1：	1
2	Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast- cancer cells显示文摘	Kaiser T Teufel I Geiger K	2013	BreastCancer Res Treat2013，140，1：	1
3	Phase II study ofneoadjuvant weekly nab-paclitaxel and carboplatin, withbevacizumab and trastuzumab, as treatment for womenwith locally advanced HER2+ breast cancer显示文摘	Yardley DA Raefsky E Castillo R	2011	Clin BreastCancer2011，115，：	1
4	Treatment andoutcomes of primary breast lymphoma显示文摘	CAON J WAI E S HART J	2012	Clin BreastCancer2012，24，：	1
5	Growth factor receptor cross- talk with estrogen receptor as a mechanism for tamoxifen resistance in breast 显示文摘	Osborne CK Schiff R	2003	BreastCancer2003，12，6：	1
6	Sex-ual functioning in long-term breast cancer survi-vors treated withadjuvant chemotherapy显示文摘	J Broeckel JA Christina L Jacobsen PB et a1	2002	BreastCancer Res Treat2002，75，3：	1
7	Platelet-derived growthfactor-D contributes to aggressiveness of breast cancer cells byup-regulating Notch and NF-κB signaling pathways显示文摘	AHMAD A WANG Z KONG D	2011	BreastCancer Research and Treatment2011，126，：	1
8	Screening and diagnosis of breast cancer in augmen- ted women 显示文摘	UEMATSU T	2008	BreastCancer2008，15，2：	1
9	Cross-resistance studiesof isogenic drug-resistant breast tumor cell lines support recentclinical evidence suggesting that sensitivity to paclitaxel may bestrongly compromised by prior doxorubicin exposure显示文摘	Guo B Villeneuve DJ Hembruff SL	2004	BreastCancer Res Treat2004，85，1：	1
10	Conservative surgery inpatients with multifocal/ multicen trie breast cancer 显示文摘	Gentilini 0 Botteri E Rotmensz N	2009	BreastCancer Res Treat2009，113，：	1
11	Histological and immu-nohistochemical analysis of apocrine breast carcinoma显示文摘	Matsuo K Fukutomi T Hasegawa T	2002	BreastCancer2002，9，1：	1
12	Diagnostic value of contrast-en-hanced ultrasound parametric imaging in breast tumors显示文摘	Yuan Z Quan J Yunxiao Z	2013	J BreastCancer2013，16，2：	1
13	On the theory of tumor self-seeding: im- plications for metastasis progression in humans 显示文摘	Aguirre-Ghiso Jh	2010	BreastCancer Res2010，12，2：	1
14	Molecular response toaromatase inhibitor treatment in primary breast cancer 显示文摘	Mackay A Urruticoechea A Dixon JM	2007	BreastCancer Res2007，9，3：	1
15	A Phase II Studyof Sagopilone (ZK 219477;ZK-EPO) in Patients WithBreast Cancer and Brain Metastases显示文摘	Freedman RA Bullitt E Sun L	2011	Clinical BreastCancer2011，11，6：	1
16	Overexpression of MMP-9 andHIF-la in Breast Cancer Cells under Hypoxic Conditions显示文摘	Choi J Y Jang Y S Min S Y	2011	J BreastCancer2011，14，2：	1
17	The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic reviewand meta-analysis 显示文摘	PETRELLI F COINU A BORGONOVO K	2014	BreastCancer Res Treat2014，144，2：	1
18	Significance and problems in evaluations of pathologi- cal responses to neoadjuvant therapy for breast cancer 显示文摘	Kurosumi M	2006	BreastCancer2006，13，3：	1
19	Genetic variants inFGFR2 and MAP3K1 are associated with the risk of familial andearly-onset breast cancer in a South-American population显示文摘	Jara L Gonzalez-Hormazabal P Cerceno K	2013	BreastCancer Res Treat2013，137，2：	1
20	Quantitative assessment of the effect ofFGFR2 gene polymorphism on the risk of breast cancer显示文摘	Jia C Cai Y Ma Y	2010	BreastCancer Res Treat2010，124，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示